Skip to content

Inspire Medical Systems INSP Proceeds from disposition of marketable securities and other investments

Proceeds from disposition of marketable securities and other investments at other companies

ResMed logo
ResMedRMD
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$204.6M+1.6%
Gross profit$176.9M+3.7%
Operating income-$1.1M+24.7%
Net income-$11.3M-477%
EPS (diluted)-$0.39-490%

Balance sheet

See full
Cash & equivalents$98.9M+83.6%
Total debt$29.6M-11.8%
Total equity$792.3M+24.6%
Total assets$911.4M+24.7%

Cash flow

See full
Operating cash flow$12.8M+292%
CapEx$9.7M+15.7%
Free cash flow$3.1M+121%

Valuation

See full
Market cap$1.24B-67.8%
Enterprise value$1.18B-69.4%
P/E9.5×-48.6×
P/S1.4×-3.2×

Profitability

See full
Gross margin85.8%+1.1pp
Operating margin5.6%-0.3pp
Net margin14.3%+6.4pp
FCF margin10.6%+1.2pp

Returns & leverage

See full
Return on equity18.4%+7.5pp
Debt / equity0.0×
Current ratio6.3×-2.7×

Where this comes from

Reported directly by Inspire Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments.

The official record: Inspire Medical Systems’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inspire Medical Systems's proceeds from disposition of marketable securities and other investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inspire Medical Systems's proceeds from disposition of marketable securities and other investments?
Inspire Medical Systems (INSP) reported proceeds from disposition of marketable securities and other investments of $55.79M in Q1 2026.
How has Inspire Medical Systems's proceeds from disposition of marketable securities and other investments changed year-over-year?
Inspire Medical Systems's proceeds from disposition of marketable securities and other investments increased by 130.8% year-over-year, from $24.17M to $55.79M.
What is the long-term trend for Inspire Medical Systems's proceeds from disposition of marketable securities and other investments?
Over 3 years (2021 to 2025), Inspire Medical Systems's proceeds from disposition of marketable securities and other investments has grown at a 92.1% compound annual growth rate (CAGR), from $43.8M to $310.38M.